InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-28.7%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Woiwode Thomas, Director. Insider active across 4 companies, notably Aligos Therapeutics, Inc.. Cumulatively, 7 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €4.8m. Activity tracked since 11 June 2021. The latest transaction was disclosed on 29 April 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
2,118,644 shares@ US$2.3617.57% mcap100.0% of flowCommon StockSEC:0000899243-22-016387:0
Ideal exit: 24 Jan 2023 (T+270)
444,744 shares0Common StockSEC:0000899243-21-034443:0
444,744 shares0Common StockSEC:0000899243-21-034443
997,940 sharesCommon StockSEC:0001140361-21-022782
997,940 sharesCommon StockSEC:0001140361-21-022782:0
485,979 shares0Common StockSEC:0000899243-21-023881
485,979 shares0Common StockSEC:0000899243-21-023881:0
7 of 7 declarations
About Woiwode Thomas
Thomas Woiwode is a Board Member at Aligos Therapeutics, Inc., Millendo Therapeutics, Inc., and Gritstone bio, Inc. He brings his expertise in governance and strategy, contributing to the direction of these companies in the biopharmaceutical sector.
